CannaPharmaRX appoints Constantine Nkafu as interim CEO, adds two directors

CANNAPHARMARX, INC.

Constantine Nkafu appointed interim CEO and board member; has led operations for past several months.
Elliot Zemel appointed to board; holds Health Canada authorization for director role.
Adam Mindle was previously designated but decided not to pursue Health Canada approval, never became director.
Board now consists of Richard Orman, Dominic Colvin, Anthony Michael Panek, Nkafu, and Zemel.
Nkafu receives $97,000 annual salary through subsidiary employment agreement with 2323414 Alberta Ltd.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed (interim)

Constantine Nkafu

Interim Chief Executive Officer

CPMD · CANNAPHARMARX, INC.

Filed: March 31, 2025, 7:59 PM ET

The Board appointed Constantine Nkafu to serve as the Company’s interim CEO.

Appointed

Elliot Zemel

Director

CPMD · CANNAPHARMARX, INC.

Filed: March 31, 2025, 7:59 PM ET

Messrs. Constantine Nkafu, Company’s interim CEO, and Elliot Zemel, have now been appointed to the Board.

Appointed

Constantine Nkafu

Director

CPMD · CANNAPHARMARX, INC.

Filed: March 31, 2025, 7:59 PM ET

Mr. Nkafu was also appointed to the Company’s Board

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Constantine Nkafu was appointed as Interim Chief Executive Officer at CANNAPHARMARX, INC..

Action: appointed
Role: Interim Chief Executive Officer

Exact text from the filing

The Board appointed Constantine Nkafu to serve as the Company’s interim CEO.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Elliot Zemel was appointed as Director at CANNAPHARMARX, INC..

Action: appointed
Role: Director

Exact text from the filing

Messrs. Constantine Nkafu, Company’s interim CEO, and Elliot Zemel, have now been appointed to the Board.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Constantine Nkafu was appointed as Director at CANNAPHARMARX, INC..

Action: appointed
Role: Director

Exact text from the filing

Mr. Nkafu was also appointed to the Company’s Board

View on SEC.gov

CANNAPHARMARX, INC. filing history →

Source: SEC EDGAR

accession 0001654954-25-003608

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.